MAUNA KEA TECHNOLOGIES (EPA:MKEA) | Finanzwire

Basculer en Français

8601	Companies
140614	Keywords
76550	Articles
75115	Press releases

Headlines Articles Press releases MAUNA KEA TECHNOLOGIES

Home
Companies
MAUNA KEA TECHNOLOGIES

BRIEF

published on 11/26/2024 at 19:15, 4 months 10 days ago

Mauna Kea Technologies Elevates Pancreatic Cancer Awareness

Innovative Technology Patient Care Early Detection Pancreatic Cancer Cellvizio®
PRESS RELEASE

published on 11/26/2024 at 19:10, 4 months 10 days ago

Inside Information / Other news releases
Mauna Kea Technologies raises awareness about pancreatic cancer during Pancreatic Cancer Awareness Month by sharing patient stories and emphasizing early detection with their p/nCLE solution

Early Detection Awareness Pancreatic Cancer Mauna Kea Technologies Patient Stories
BRIEF

published on 11/20/2024 at 18:53, 4 months 16 days ago

End of the liquidity contract between Mauna Kea Technologies and Gilbert Dupont

Securities Liquidity Contract Termination Gilbert Dupont Mauna Kea
BRIEF

published on 11/13/2024 at 12:21, 4 months 24 days ago

Mauna Kea Technologies: Review of recent developments

Funding Mauna Kea Technologies Cellvizio CellTolerance Food Intolerances
PRESS RELEASE

published on 11/13/2024 at 12:16, 4 months 24 days ago

Inside Information / Other news releases
Mauna Kea Technologies provides an update on recent developments including the launch of its CellTolerance program for food intolerances and strategic initiatives to strengthen its financial structure and commercialize innovative solutions

Financial Structure Update Commercialization Mauna Kea Technologies CellTolerance Program
BRIEF

published on 10/17/2024 at 08:05, 5 months 21 days ago

Mauna Kea Technologies Shows Positive Clinical Results for Cellvizio in IBS

Clinical Study Mauna Kea Technologies Cellvizio IBS Management Gut Barrier Dysfunction
PRESS RELEASE

published on 10/17/2024 at 08:00, 5 months 21 days ago

Inside Information / Other news releases
Mauna Kea Technologies announces new positive clinical results for Cellvizio in food intolerance at UEG Week 2024, highlighting the value of Confocal Laser Endomicroscopy in managing IBS patients

IBS Mauna Kea Technologies Cellvizio Clinical Results Food Intolerance
BRIEF

published on 10/04/2024 at 17:50, 6 months 2 days ago

Evolution of the share capital and voting rights of Mauna Kea Technologies

Share Capital Voting Rights Euronext Growth Mauna Kea Technologies PACEO Financing
PRESS RELEASE

published on 10/04/2024 at 17:45, 6 months 2 days ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Mauna Kea Technologies reports monthly update on voting rights and shares. New shares issued under PACEO financing facility. Company specializes in real-time cellular imaging for medical diagnosis

Voting Rights Shares Medical Device Mauna Kea Technologies Cellvizio Platform
BRIEF

published on 07/17/2024 at 17:50, 8 months 20 days ago

Half-year review of the Mauna Kea Technologies liquidity contract

Liquidity Contract Actions Gilbert Dupont Mauna Kea Technologies First Half Of 2024

Accesswire

Published on 04/07/2025 at 14:00, 12 minutes ago

NOA Lithium Advances Towards 2025 Water Exploration at Rio Grande Project
Published on 04/07/2025 at 14:00, 12 minutes ago

Rio Grande Resources Announces the Successful Completion of Sampling and Field Campaign at the Winston Gold-Silver Project
Published on 04/07/2025 at 14:00, 12 minutes ago

Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology
Published on 04/07/2025 at 14:00, 12 minutes ago

Newsmax’s Audience Grows by 50% in Q1 2025
Published on 04/07/2025 at 14:00, 12 minutes ago

GPOX Reports Record Quarterly Revenue with Significantly Improved Gross Margins

View all ACCESSWIRE

EQS Group

Published on 04/07/2025 at 13:00, 1 hour 12 minutes ago

CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer
Published on 04/07/2025 at 12:57, 1 hour 14 minutes ago

PFISTERER acquires long-standing partner Power CSL - portfolio expanded to include subsea solutions
Published on 04/07/2025 at 11:57, 2 hours 14 minutes ago

Share buyback: Announcement pursuant to Article 5 (1) (b) and (3) of Regulation (EU) No. 596/2014
Published on 04/07/2025 at 11:44, 2 hours 27 minutes ago

EQS-Adhoc: Rubean AG: Change in the Supervisory Board
Published on 04/07/2025 at 10:30, 3 hours 41 minutes ago

Original-Research: UmweltBank AG (von GBC AG): Buy

Les Echos

Published on 04/07/2025 at 07:01, 7 hours 11 minutes ago

bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 18 hours ago

Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 18:17, 2 days 19 hours ago

Reporting on share buyback transactions carried out between March 31 and April 3, 2025
Published on 04/04/2025 at 18:13, 2 days 19 hours ago

Total number of voting rights and shares making up the share capital at March 31, 2025
Published on 04/04/2025 at 17:45, 2 days 20 hours ago

March 2025

View all LES ECHOS COMFI WIRE